In vivo activity of HSR-903, a new fluoroquinolone, against respiratory pathogens.
about
Comparative in vitro antimicrobial activities of the newly synthesized quinolone HSR-903, sitafloxacin (DU-6859a), gatifloxacin (AM-1155), and levofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complexIn vitro activity of HSR-903, a new oral quinolone, against bacteria causing respiratory infections.In vivo efficacy of telithromycin (HMR3647) against Streptococcus pneumoniae and Haemophilus influenzae
P2860
In vivo activity of HSR-903, a new fluoroquinolone, against respiratory pathogens.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
In vivo activity of HSR-903, a new fluoroquinolone, against respiratory pathogens.
@en
In vivo activity of HSR-903, a new fluoroquinolone, against respiratory pathogens.
@nl
type
label
In vivo activity of HSR-903, a new fluoroquinolone, against respiratory pathogens.
@en
In vivo activity of HSR-903, a new fluoroquinolone, against respiratory pathogens.
@nl
prefLabel
In vivo activity of HSR-903, a new fluoroquinolone, against respiratory pathogens.
@en
In vivo activity of HSR-903, a new fluoroquinolone, against respiratory pathogens.
@nl
P2093
P2860
P356
P1476
In vivo activity of HSR-903, a new fluoroquinolone, against respiratory pathogens
@en
P2093
K Yamaguchi
S Miyazaki
S Yoshizumi
P2860
P304
P356
10.1128/AAC.42.4.785
P407
P577
1998-04-01T00:00:00Z